Marksans Pharma Limited (BOM:524404)
236.15
+8.60 (3.78%)
At close: Jul 30, 2025
Marksans Pharma Employees
Marksans Pharma had 1,840 employees as of March 31, 2025. The number of employees increased by 699 or 61.26% compared to the previous year.
Employees
1,840
Change (1Y)
699
Growth (1Y)
61.26%
Revenue / Employee
$14,254,592
Profits / Employee
$2,068,342
Market Cap
101.90B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1,840 | 699 | 61.26% |
Mar 31, 2024 | 1,141 | 289 | 33.92% |
Mar 31, 2023 | 852 | -38 | -4.27% |
Mar 31, 2022 | 890 | -248 | -21.79% |
Mar 31, 2021 | 1,138 | -12 | -1.04% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Reliance Industries | 347,362 |
HDFC Bank | 214,521 |
Bharti Airtel | 13,593 |
Tata Consultancy Services | 607,979 |
ICICI Bank | 182,665 |
State Bank of India | 236,226 |
Infosys | 323,578 |
Hindustan Unilever | 18,802 |
Marksans Pharma News
- 4 weeks ago - Marksans Pharma receives EIR from USFDA for Time-Cap Labs facility - Business Upturn
- 6 weeks ago - Marksans Pharma’s UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution - Business Upturn
- 7 weeks ago - Marksans Pharma shares jump 3% after large block deal worth Rs 257 crore - Business Upturn
- 7 weeks ago - Marksans Pharma Block Deal: Over 1 crore shares worth Rs 257 crore change hands at Rs 249.95 per share - Business Upturn
- 2 months ago - Marksans Pharma’s subsidiary Relonchem gets UK MHRA approval for Metformin Hydrochloride Oral Solution - Business Upturn
- 2 months ago - Marksans Pharma’s UK arm gets marketing approval for Sennosides 7.5 mg tablets - Business Upturn
- 2 months ago - Marksans Pharma’s UK subsidiary Relonchem gets UKMHRA nod for Gabapentin oral solution - Business Upturn
- 3 months ago - Marksans Pharma’s subsidiary receives one USFDA observation after cGMP inspection at New York facility - Business Upturn